Symbol | Exchange | Currency |
|---|
Investing.com – U.S. stocks were lower after the close on Thursday, as losses in the Oil & Gas, Telecoms and Consumer Goods sectors led shares lower. At the close in NYSE, the Dow...
Investing.com – U.S. stocks were higher after the close on Wednesday, as gains in the Oil & Gas, Financials and Industrials sectors led shares higher. At the close in NYSE, the...
Aditx Therapeutics announced that the healthcare services company HealthBar will offer AditxtScore for COVID-19across the state of Michigan.HealthBar with services...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Sell | Sell |
| Technical Indicators | Strong Buy | Strong Buy | Neutral | Sell | Sell |
| Summary | Strong Buy | Strong Buy | Buy | Sell | Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 146.92 | 147.47 | 145.56 | +0.09 | +0.06% | 53.16M | NASDAQ | |||
| 352.96 | 354.35 | 342.37 | +7.00 | +2.02% | 18.74M | NASDAQ | |||
| 2,844.30 | 2,846.60 | 2,804.80 | +20.0 | +0.71% | 1.14M | NASDAQ | |||
| 100.60 | 100.97 | 99.65 | +0.54 | +0.54% | 8.16M | NYSE | |||
| 145.08 | 148.00 | 144.57 | -6.11 | -4.04% | 31.53M | NYSE | |||
| 43.94 | 44.41 | 43.81 | -0.25 | -0.57% | 16.00M | NYSE | |||
| 27.13 | 27.38 | 27.10 | -0.06 | -0.22% | 24.40M | NYSE | |||
| 13.78 | 13.94 | 13.64 | +0.07 | +0.51% | 57.09M | NYSE | |||
| 163.04 | 163.59 | 160.82 | +1.86 | +1.15% | 9.67M | NYSE | |||
| 220.81 | 221.49 | 218.61 | -4.01 | -1.78% | 20.83M | NASDAQ | |||
| 19.64 | 19.84 | 19.42 | -0.75 | -3.68% | 50.52K | OTC Markets | |||
| 16.16 | 16.25 | 16.15 | -0.06 | -0.37% | 4.31M | NASDAQ | |||
| 231.82 | 235.31 | 229.17 | -5.68 | -2.39% | 3.70M | NASDAQ | |||
| 185.16 | 191.72 | 184.11 | -6.08 | -3.18% | 1.66M | NYSE | |||
| 2,852.70 | 2,858.10 | 2,817.00 | +16.1 | +0.57% | 741.74K | NASDAQ |
Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune reprogramming and monitoring. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues. The company is also developing ADi products for organ transplantation, including skin grafting, autoimmune diseases, and allergies. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.